Table 5.

Mean ±s.d.Δblood[lactate], end-exercise heart rate and heart rate kinetics during moderate, heavy and severe exercise in the control and RhEPO treatment groups

	Control-Pre	Control-Post	RhEPO-Pre	RhEPO-Post
Moderate exercise
ΔBlood [lactate] (mm)	0.3 ± 0.3	0.4 ± 0.3	0.2 ± 0.3	0.4 ± 0.4
End-exercise HR (beats min−1)	120 ± 13	125 ± 13	115 ± 12	113 ± 11
HR time constant (s)	24 ± 10	33 ± 18	23 ± 17	26 ± 15
Heavy exercise
ΔBlood[lactate] (mm)	6.9 ± 1.6	7.0 ± 0.8	6.5 ± 2.1	5.5 ± 1.5
End-exercise HR (beatsmin−1)	176 ± 8	177 ± 8	174 ± 12	172 ± 13
HR time constant (s)	44 ± 17	38 ± 8	50 ± 19	49 ± 17
Severe exercise
ΔBlood[lactate] (mm)	5.4 ± 1.7	4.4 ± 2.0	3.9 ± 1.5	4.5 ± 1.6
End-exercise HR (beats min−1)	178 ± 7	177 ± 7	180 ± 6	182 ± 6
HR time constant (s)	37 ± 14	45 ± 20	53 ± 29	64 ± 31